Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.
Press releases published on July 2, 2025
Inventiva announces the publication in Journal of Hepatology Reports on results of lanifibranor treatment on liver sinusoidal endothelial cells in patients with MASLD/MASH and in preclinical models of the disease
GlobeNewswire
·
July 2, 2025
Analysis of liver sinusoidal endothelial cells (“LSEC”) from screening and end of treatment biopsies in the Phase 2b NATIVE study showed evidence of LSEC capillarization in patients without MASH, and a further increased capillarization in patients with …
Phoenix Accident Doctors Unveils a New Way to End Car Accident Pain Permanently Without Surgery
GlobeNewswire
·
July 2, 2025
Phoenix, Arizona, July 02, 2025 (GLOBE NEWSWIRE) -- Dr. Thanh Nguyen of The Accident Doctors AZ has created an innovative platelet treatment that resolves chronic pain with an over 90% success rate by harnessing the body's natural healing abilities. …
New Study: 4 in 5 Americans Have Experienced Heat Exhaustion Symptoms, Ergodyne Finds
GlobeNewswire
·
July 2, 2025
St. Paul, MN, July 02, 2025 (GLOBE NEWSWIRE) -- 4 in 5 Americans have experienced the warning signs of heat exhaustion, according to a new survey for Extreme Heat Month this July from pioneering safety work gear provider Ergodyne. The survey marks the …
Mesa Laboratories, Inc. to Announce First Quarter Results on August 5, 2025
GlobeNewswire
·
July 2, 2025
LAKEWOOD, Colo., July 02, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the first quarter of fiscal year 2026 at approximately 8:00 A.M. Eastern time on Tuesday, August 5, 2025. About …
Emerging Clinical Trial Infrastructure in the MENA Region: A Comprehensive Market Analysis
GlobeNewswire
·
July 2, 2025
Boston, July 02, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Clinical Trial Infrastructure Regional Analysis Market: Middle East and North Africa” is expected to reach $1.3 billion by the end of 2029 at a compound annual …
Financing Innovation: Proposal for Novel Adaptive Platform Trial Fund Offers New Model for ALS Drug Development
GlobeNewswire
·
July 2, 2025
Cambridge, Mass., July 02, 2025 (GLOBE NEWSWIRE) -- A team of researchers from the MIT Sloan School of Management, the Sean M. Healey …
Global Real-World Evidence Solution Market to Grow at a Substantial Growth Rate of ~8% by 2032 | DelveInsight
GlobeNewswire
·
July 2, 2025
New York, USA, July 02, 2025 (GLOBE NEWSWIRE) -- Global Real-World Evidence Solution Market to Grow at a Substantial Growth Rate of ~8% by 2032 | DelveInsight The real-world evidence solutions market is largely driven by the increasing prevalence of …
I-Mab Presents Positive Givastomig Phase 1b Dose Escalation Data in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers at ESMO GI 2025
GlobeNewswire
·
July 2, 2025
Data show confirmed ORR of 83% (10/12) at doses selected for ongoing expansion study Median follow-up of 9.0 months as of the updated data cutoff Responses observed in patients with low PD-L1 and/or CLDN18.2 expression Company to host investor event on …
Lynozyfic™ (linvoseltamab-gcpt) Receives FDA Accelerated Approval for Treatment of Relapsed or Refractory Multiple Myeloma
GlobeNewswire
·
July 2, 2025
TARRYTOWN, N.Y., July 02, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Lynozyfic™ (linvoseltamab-gcpt) to treat adult patients …
Houston to host 2025 AAU Junior Olympic Games July 22 - August 2
GlobeNewswire
·
July 2, 2025
Houston, TX, July 02, 2025 (GLOBE NEWSWIRE) -- The Amateur Athletic Union (AAU), in conjunction with the Harris County - Houston Sports Authority (HCHSA), will host the 2025 AAU Junior Olympic Games in five (5) different venues across the Greater Houston …
U.S. Oral Surgery Management Names Doug Drew CEO
GlobeNewswire
·
July 2, 2025
IRVING, Texas, July 02, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) developed and implemented a succession plan earlier this year to ensure a smooth transition from long- time CEO, Richard Hall. Hall is transitioning from his role as …
Intuitive’s da Vinci 5 Surgical System Receives CE Mark
GlobeNewswire
·
July 2, 2025
SUNNYVALE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the da Vinci 5 Surgical System has received CE mark …
US Probiotics Market Poised for Strong Growth Amid Surging Demand for Digestive Health Solutions
GlobeNewswire
·
July 2, 2025
Delray Beach, FL, July 02, 2025 (GLOBE NEWSWIRE) -- A new research report, “US Probiotics Market by Ingredient (Bacteria and Yeast), Product Type (Functional Food …
Athelas Launches AIR: The Only EHR with Fully Integrated Ambient Scribing, AI Agents, and Hands-Free RCM Automation
GlobeNewswire
·
July 2, 2025
MOUNTAIN VIEW, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Athelas, healthcare technology company powered by Commure, today announced the launch of Athelas AIR, its next-generation electronic health record (EHR) system designed to meet the needs of health …
Cyclacel Pharmaceuticals Announces Stock Split
GlobeNewswire
·
July 2, 2025
BERKELEY HEIGHTS, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced that it expects to implement a …
Windtree Announces Issuance of Istaroxime Patent for the United States for Acute Heart Failure
GlobeNewswire
·
July 2, 2025
1.3 million patients are hospitalized annually in the U.S. from acute heart failure and it is the #1 cause of hospitalization in patients >65 years old If istaroxime is approved in the US for acute heart failure, this patent would provide protection to …
Primo Biotechnology Secures A Funding and Targets 2026 IPO to Strengthen Global Radiopharmaceutical Strategy
GlobeNewswire
·
July 2, 2025
TAIPEI, Taiwan, July 02, 2025 (GLOBE NEWSWIRE) -- Primo Biotechnology Co., Ltd., a pioneering radiopharmaceutical company in Taiwan, announced the successful completion of its NT$220 million Series A funding round. With total capital raised now exceeding …
AIM ImmunoTech Announces Recent Presentation on the Potential of Private-Public Partnerships for the Development of Oncology Therapies
GlobeNewswire
·
July 2, 2025
OCALA, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a presentation and discussion on immunotherapies involving AIM’s drug Ampligen at the recent U.S.-Poland Science and Technology …
The International Myeloma Foundation Proudly Announces EMA-CHMP Positive Qualification Advice to i2TEAMM Novel Biomarker Procedure Application on the Use of MRDnegCR as an Intermediate Early Endpoint for Conditional Market Approval in Myeloma Clinical…
GlobeNewswire
·
July 2, 2025
STUDIO CITY, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) and the collaborative stakeholder group i2TEAMM (International Independent Team for Endpoint Approval of Myeloma MRD), which includes top global myeloma …
AMN Healthcare Sells Smart Square Scheduling Technology to symplr, Creates Commercial Partnership to Deliver Comprehensive Healthcare Workforce Solutions
GlobeNewswire
·
July 2, 2025
DALLAS, July 02, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE: AMN), the leader in total healthcare talent solutions, today announced the sale of its Smart Square® scheduling software to symplr®, a leader in enterprise healthcare operations software. In …